Mesa Labs director acquires 2,784 shares via RSUs
Mesa Laboratories, Inc. (MLAB) director Shannon Hall reported the vesting and settlement of 2,784 Restricted Stock Units into an equal number of shares of common stock on August 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mesa Laboratories, Inc. (MLAB) director Shannon Hall reported the vesting and settlement of 2,784 Restricted Stock Units into an equal number of shares of common stock on August 15, 2026. The derivative RSU position was reduced to zero, and Hall now directly holds 6,973 shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units - 8 F1, F2, F3 | 2,784 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,784 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each RSU represents a contingent right to receive one share of the Issuer's common stock
- F2. RSUs that vested on August 15, 2026
- F3. Not Applicable
Key Figures
Key Terms
Restricted Stock Units financial
derivative security financial
Rule 10b5-1 trading plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Shannon Hall report for MLAB on August 15, 2026?
How many Mesa Laboratories (MLAB) RSUs did Shannon Hall convert to common stock?
What is Shannon Hall’s direct common stock holding in MLAB after this Form 4?
Were Shannon Hall’s MLAB transactions under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.